These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10757123)

  • 1. Expression of thioredoxin and glutaredoxin, redox-regulating proteins, in pancreatic cancer.
    Nakamura H; Bai J; Nishinaka Y; Ueda S; Sasada T; Ohshio G; Imamura M; Takabayashi A; Yamaoka Y; Yodoi J
    Cancer Detect Prev; 2000; 24(1):53-60. PubMed ID: 10757123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thioredoxin is downstream of Smad7 in a pathway that promotes growth and suppresses cisplatin-induced apoptosis in pancreatic cancer.
    Arnold NB; Ketterer K; Kleeff J; Friess H; Büchler MW; Korc M
    Cancer Res; 2004 May; 64(10):3599-606. PubMed ID: 15150118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of thioredoxin/adult T-cell leukemia-derived factor in cisplatin-resistant human cancer cell lines.
    Yamada M; Tomida A; Yoshikawa H; Taketani Y; Tsuruo T
    Clin Cancer Res; 1996 Feb; 2(2):427-32. PubMed ID: 9816187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced coexpression of thioredoxin and high mobility group protein 1 genes in human hepatocellular carcinoma and the possible association with decreased sensitivity to cisplatin.
    Kawahara N; Tanaka T; Yokomizo A; Nanri H; Ono M; Wada M; Kohno K; Takenaka K; Sugimachi K; Kuwano M
    Cancer Res; 1996 Dec; 56(23):5330-3. PubMed ID: 8968078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Widespread expression of thioredoxin and thioredoxin reductase in non-small cell lung carcinoma.
    Soini Y; Kahlos K; Näpänkangas U; Kaarteenaho-Wiik R; Säily M; Koistinen P; Pääakkö P; Holmgren A; Kinnula VL
    Clin Cancer Res; 2001 Jun; 7(6):1750-7. PubMed ID: 11410516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurements of plasma glutaredoxin and thioredoxin in healthy volunteers and during open-heart surgery.
    Nakamura H; Vaage J; Valen G; Padilla CA; Björnstedt M; Holmgren A
    Free Radic Biol Med; 1998 May; 24(7-8):1176-86. PubMed ID: 9626572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the inhibition of mammalian thioredoxin, thioredoxin reductase, and glutaredoxin by cis-diamminedichloroplatinum (II) and its major metabolite, the glutathione-platinum complex.
    Arnér ES; Nakamura H; Sasada T; Yodoi J; Holmgren A; Spyrou G
    Free Radic Biol Med; 2001 Nov; 31(10):1170-8. PubMed ID: 11705695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of thioredoxin-interacting protein 1 as a hypoxia-inducible factor 1alpha-induced gene in pancreatic cancer.
    Baker AF; Koh MY; Williams RR; James B; Wang H; Tate WR; Gallegos A; Von Hoff DD; Han H; Powis G
    Pancreas; 2008 Mar; 36(2):178-86. PubMed ID: 18376310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thioredoxin induced antioxidant gene expressions in human lens epithelial cells.
    Yegorova S; Yegorov O; Lou MF
    Exp Eye Res; 2006 Oct; 83(4):783-92. PubMed ID: 16712839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The thioredoxin-thioredoxin reductase system: over-expression in human cancer.
    Lincoln DT; Ali Emadi EM; Tonissen KF; Clarke FM
    Anticancer Res; 2003; 23(3B):2425-33. PubMed ID: 12894524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High redox thioredoxin but low thioredoxin reductase activities in the serum of patients with rheumatoid arthritis.
    Lemarechal H; Allanore Y; Chenevier-Gobeaux C; Ekindjian OG; Kahan A; Borderie D
    Clin Chim Acta; 2006 May; 367(1-2):156-61. PubMed ID: 16458876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of some Mannich bases on heat shock proteins HSC70 and GRP75, and thioredoxin and glutaredoxin levels in Jurkat cells.
    Gul M; Atalay M; Gul HI; Nakao C; Lappalainen J; Hänninen O
    Toxicol In Vitro; 2005 Aug; 19(5):573-80. PubMed ID: 15896550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thioredoxin and thioredoxin reductase expression in thyroid cancer depends on tumour aggressiveness.
    Lincoln DT; Al-Yatama F; Mohammed FM; Al-Banaw AG; Al-Bader M; Burge M; Sinowatz F; Singal PK
    Anticancer Res; 2010 Mar; 30(3):767-75. PubMed ID: 20392995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of glutaredoxin and thioredoxin during monocytic differentiation.
    Takashima Y; Hirota K; Nakamura H; Nakamura T; Akiyama K; Cheng FS; Maeda M; Yodoi J
    Immunol Lett; 1999 Jun; 68(2-3):397-401. PubMed ID: 10424449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Change of redox status and modulation by thiol replenishment in retinal photooxidative damage.
    Tanito M; Nishiyama A; Tanaka T; Masutani H; Nakamura H; Yodoi J; Ohira A
    Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2392-400. PubMed ID: 12091442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thioredoxin reductase, a redox-active selenoprotein, is secreted by normal and neoplastic cells: presence in human plasma.
    Söderberg A; Sahaf B; Rosén A
    Cancer Res; 2000 Apr; 60(8):2281-9. PubMed ID: 10786696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and potential function of the CXC chemokine CXCL16 in pancreatic ductal adenocarcinoma.
    Wente MN; Gaida MM; Mayer C; Michalski CW; Haag N; Giese T; Felix K; Bergmann F; Giese NA; Friess H
    Int J Oncol; 2008 Aug; 33(2):297-308. PubMed ID: 18636150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human thioredoxin-1 ameliorates experimental murine colitis in association with suppressed macrophage inhibitory factor production.
    Tamaki H; Nakamura H; Nishio A; Nakase H; Ueno S; Uza N; Kido M; Inoue S; Mikami S; Asada M; Kiriya K; Kitamura H; Ohashi S; Fukui T; Kawasaki K; Matsuura M; Ishii Y; Okazaki K; Yodoi J; Chiba T
    Gastroenterology; 2006 Oct; 131(4):1110-21. PubMed ID: 17030181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thioredoxin expression is associated with lymph node status and prognosis in early operable non-small cell lung cancer.
    Kakolyris S; Giatromanolaki A; Koukourakis M; Powis G; Souglakos J; Sivridis E; Georgoulias V; Gatter KC; Harris AL
    Clin Cancer Res; 2001 Oct; 7(10):3087-91. PubMed ID: 11595699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ductal neoplasia of the pancreas: nosologic, clinicopathologic, and biologic aspects.
    Adsay NV; Basturk O; Cheng JD; Andea AA
    Semin Radiat Oncol; 2005 Oct; 15(4):254-64. PubMed ID: 16183479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.